Varga VL - Search Results

1

Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides.

Hegyesi H, Somlai B, Varga VL, Toth G, Kovacs P, Molnar EL, Laszlo V, Karpati S, Rivera E, Falus A, Darvas Z. Hegyesi H, et al. Among authors: varga vl. J Invest Dermatol. 2001 Jul;117(1):151-3. doi: 10.1046/j.0022-202x.2001.01406.x. J Invest Dermatol. 2001. PMID: 11442763 Free article.

2

Inhibition of IgE production by epsilon (epsilon) chain-specific antisense oligonucleotides (AOs) studied on human myeloma cell line U266 and peripheral blood mononuclear cells of a patient with hypereosinophilia.

Fekete B, Sági J, Szemzõ A, Kovács L, Pálóczi K, Varga VL, Tamássy K, Falus A. Fekete B, et al. Among authors: varga vl. Immunol Lett. 1997 Aug;58(3):181-90. doi: 10.1016/s0165-2478(97)00082-5. Immunol Lett. 1997. PMID: 9293401

3

H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells.

Radvány Z, Darvas Z, Kerekes K, Prechl J, Szalai C, Pállinger E, Valéria L, Varga VL, Sandor M, Erdei A, Falus A. Radvány Z, et al. Among authors: varga vl. Semin Cancer Biol. 2000 Feb;10(1):41-5. doi: 10.1006/scbi.2000.0306. Semin Cancer Biol. 2000. PMID: 10888270 Review.

4

gp130-specific antisense oligonucleotides inhibit IL-6 signal inducing junB mRNA transcription in the human hepatoma cell line, HepG2.

Varga VL, Fülöp AK, Holub MC, Tóth S, Szalai C, Falus A. Varga VL, et al. Cell Biol Int. 2001;25(8):835-40. doi: 10.1006/cbir.2001.0765. Cell Biol Int. 2001. PMID: 11482910

5

Childhood-onset mild cutaneous porphyria with compound heterozygotic mutations in the uroporphyrinogen decarboxylase gene.

Remenyik E, Lecha M, Badenas C, Kószó F, Vass V, Herrero C, Varga V, Emri G, Balogh A, Horkay I. Remenyik E, et al. Clin Exp Dermatol. 2008 Aug;33(5):602-5. doi: 10.1111/j.1365-2230.2008.02734.x. Epub 2008 May 6. Clin Exp Dermatol. 2008. PMID: 18462440

6

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study.

Márk Á, Hajdu M, Váradi Z, Sticz TB, Nagy N, Csomor J, Berczi L, Varga V, Csóka M, Kopper L, Sebestyén A. Márk Á, et al. BMC Cancer. 2013 May 22;13:250. doi: 10.1186/1471-2407-13-250. BMC Cancer. 2013. PMID: 23693095 Free PMC article.

7

Application of Injectable, Crosslinked, Fibrin-Containing Hyaluronic Acid Scaffolds for In Vivo Remodeling.

Hinsenkamp A, Fülöp Á, Hricisák L, Pál É, Kun K, Majer A, Varga V, Lacza Z, Hornyák I. Hinsenkamp A, et al. J Funct Biomater. 2022 Aug 13;13(3):119. doi: 10.3390/jfb13030119. J Funct Biomater. 2022. PMID: 35997457 Free PMC article.

8

Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.

Nagy Z, Kószó F, Pár A, Emri G, Horkay I, Horányi M, Karádi O, Rumi G Jr, Morvay M, Varga V, Dobozy A, Mózsik G. Nagy Z, et al. Liver Int. 2004 Feb;24(1):16-20. doi: 10.1111/j.1478-3231.2004.00884.x. Liver Int. 2004. PMID: 15101996

9

Photosensitivity skin disorders in childhood.

Horkay I, Emri G, Varga V, Simics E, Remenyik E. Horkay I, et al. Photodermatol Photoimmunol Photomed. 2008 Apr;24(2):56-60. doi: 10.1111/j.1600-0781.2008.00341.x. Photodermatol Photoimmunol Photomed. 2008. PMID: 18353083 Review.

10

[Porphyria cutanea tarda and hepatitis C virus].

Emri G, Tornai I, Pósán E, Seszták T, Varga V, Horkay I. Emri G, et al. Orv Hetil. 2001 Nov 25;142(47):2635-9. Orv Hetil. 2001. PMID: 11778362 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters